Innovative Machine Learning Framework for Anticipating Synergistic Effects in Cancer Drug Therapy

Bioinformatics has led to improvements in cancer treatment and longevity. Cancer, caused by alterations and mutations in a patient's cell genes, is very difficult to cure, especially in the tumor surroundings. Since different individuals react differentially to the same cancer medications, more individualized therapies are required. In order to identify new medications more quickly, researchers are looking for replacements to clinical studies. The industry has been driven by big data in the fields of cancer and pharmacogenomics. In order to make sense of this information and propel advances in cancer treatment, data analysis and artificial intelligence are vital. Both structural and functional similarities between drugs and between drugs and tissues in terms of expression of genes are essential for the target function. To discover synergistic pharmaceutical combinations towards avoiding cancer, we provide a comprehensive technique. Through the use of features derived from specific medication response data, our comprehensive technique is able to anticipate drug interactions. To find synergistic medication combinations, this study used a combination drug screen to generate useful characteristics. We have compared the models that have been trained using assessments of performance metrics including sensitivity, accuracy, and specificity. Among the models tested, the Random Forest model performed the best. The optimal model is found by comparing trained models using performance metrics like sensitivity, accuracy, and specificity. In tests comparing several models, randomly generated forest systems consistently outperformed the competition. Both the Braf-synergy and Braf-effective models, which make use of the random forest model, achieve a success rate of 95.45 and 97.16, respectively.